Status:
ACTIVE_NOT_RECRUITING
Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes
Lead Sponsor:
Portsmouth Hospitals NHS Trust
Collaborating Sponsors:
Abbott
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Brief Summary
Gestational diabetes (GDM) develops during pregnancy and is becoming increasingly common. The condition is associated with adverse outcomes for mother and baby during both the pregnancy and delivery p...
Detailed Description
Gestational Diabetes (GDM) is associated with higher than normal blood sugar levels in pregnant women which has the potential to harm the baby and mother. The condition resolves with delivery of the b...
Eligibility Criteria
Inclusion
- Female aged 18 years of above
- Between 12-26 weeks gestation
- Identified by NICE as having one or more independent risk factor for GDM
- Suitable for the standard care pathway under the joint antenatal clinic for GDM
- Willing and able to give informed consent.
Exclusion
- Pre-existing diabetes
- Previous GDM
- Unsuitable for standard joint antenatal clinic pathway
- Known allergy to freestyle libre adhesive pad
- Planning to move geographical area during the study timeframe
- Participating in a different study that could interfere with glucose levels or affect ability to participate.
Key Trial Info
Start Date :
November 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 21 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05981547
Start Date
November 22 2023
End Date
June 21 2026
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Portsmouth Hospitals University NHS Trust
Portsmouth, United Kingdom